689
Views
0
CrossRef citations to date
0
Altmetric
Editorial

Current medicines hold promise in the treatment of orphan infections due to brain-eating amoebae

ORCID Icon, , , & ORCID Icon
Pages 227-235 | Received 21 Sep 2021, Accepted 03 Mar 2022, Published online: 14 Mar 2022

Figures & data

Figure 1. Central nervous system infections due to brain-eating amoebae are challenging to treat with extremely poor prognosis. Re-purposing clinically used drugs for neuropathological conditions that are blood-brain barrier permeable, as well as parasite-specific compounds developed against related protozoa are potential avenues to design chemotherapeutics against orphan infections due to pathogenic free-living amoebae.

Figure 1. Central nervous system infections due to brain-eating amoebae are challenging to treat with extremely poor prognosis. Re-purposing clinically used drugs for neuropathological conditions that are blood-brain barrier permeable, as well as parasite-specific compounds developed against related protozoa are potential avenues to design chemotherapeutics against orphan infections due to pathogenic free-living amoebae.

Table 1. List of compounds targeting ergosterol

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.